These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15473671)

  • 1. Effect of glycyrrhizic acid on protein binding of diltiazem, verapamil, and nifedipine.
    Lee KJ; Park HJ; Shin YH; Lee CH
    Arch Pharm Res; 2004 Sep; 27(9):978-83. PubMed ID: 15473671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of glycyrrhizin to human serum and human serum albumin.
    Ishida S; Sakiya Y; Ichikawa T; Kinoshita M; Awazu S
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):226-8. PubMed ID: 2720854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of the calcium antagonist [3H]verapamil to membrane fractions from plants.
    Andrejauskas E; Hertel R; Marmé D
    J Biol Chem; 1985 May; 260(9):5411-4. PubMed ID: 3157687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biochromatographic framework to evaluate the calcium effect on the antihypertensive molecule-human serum albumin binding.
    André C; Thomassin M; Guyon C; Truong TT; Guillaume YC
    J Pharm Biomed Anal; 2003 Jun; 32(2):217-23. PubMed ID: 12763531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizin binding site on human serum albumin.
    Ishida S; Kinoshita M; Sakiya Y; Taira Z; Ichikawa T
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):275-8. PubMed ID: 1576687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of diltiazem and other calcium entry blockers.
    Hermann P; Morselli PL
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of calcium antagonists].
    Lauterburg BH
    Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of bepridil.
    Pritchard JF; McKown LA; Dvorchik BH; O'Neill PJ
    J Clin Pharmacol; 1985; 25(5):347-53. PubMed ID: 3875635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical differentiation of nifedipine and other calcium antagonists.
    Ebner F; Donath M; Rämsch KD
    Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.